Form 4 for NEO NEOGENOMICS INC
Accepted 2022-04-04 00:00:00 ET · period of report 2022-04-01 · accession 0001077183-22-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 | 2022-04-01 | NEO | Brown Douglas Matthew | Chief Strategy Off | A - Grant | $0.00 | +82.3K | 158.7K | +108% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | A | A | 82,305 | $0.00 | 158,684 | D | — | — | (F1) On April 1, 2022, Mr. Brown was granted 82,305 restricted stock awards. These awards vest on the first anniversary date of the grant date. |